Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Библиографические подробности
Главные авторы:	Hennekens, C, Buring, J, Sandercock, P, Collins, R, Peto, R
Формат:	Journal article
Язык:	English
Опубликовано:	1989

Схожие документы

Aspirin and stroke.
по: Buring, J, и др.
Опубликовано: (1990)

ASPIRIN USE AND CHRONIC DISEASES
по: Hennekens, C, и др.
Опубликовано: (1990)

Aspirin in ischemic heart disease.
по: Hennekens, C, и др.
Опубликовано: (1992)

Low-dose aspirin for migraine prophylaxis.
по: Buring, J, и др.
Опубликовано: (1990)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
по: Baigent, C, и др.
Опубликовано: (2009)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
по: Hennekens, C, и др.
Опубликовано: (1996)

Antiplatelet agents in stroke prevention.
по: Peto, R
Опубликовано: (1988)

Aspirin in the primary prevention of vascular disease Reply
по: Baigent, C, и др.
Опубликовано: (2009)

Aspirin in the primary prevention of vascular disease Reply
по: Baigent, C, и др.
Опубликовано: (2009)

Prevention. Aspirin in primary prevention--good news and bad news.
по: Hennekens, C, и др.
Опубликовано: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
по: Hennekens, C, и др.
Опубликовано: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
по: Collins, R, и др.
Опубликовано: (1994)

TRIALS OF ANTIPLATELET THERAPY - REPLY
по: Baigent, C, и др.
Опубликовано: (1994)

Polypills with or without aspirin for primary prevention of cardiovascular disease
по: Mant, J, и др.
Опубликовано: (2021)

Role of aspirin in primary prevention of cardiovascular disease
по: Patrono, C, и др.
Опубликовано: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
по: VanWormer JJ, и др.
Опубликовано: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
по: Ying Xing, и др.
Опубликовано: (2019-07-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Опубликовано: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
по: Randall S Stafford, и др.
Опубликовано: (2005-12-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
по: Guillaume Marquis‐Gravel, и др.
Опубликовано: (2024-02-01)

An overview of the British and American aspirin studies.
по: Hennekens, C, и др.
Опубликовано: (1988)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
по: Hennekens, C, и др.
Опубликовано: (2006)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
по: L. O. Minushkina
Опубликовано: (2017-12-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
по: Lozano R, и др.
Опубликовано: (2015-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
по: Yinong Chen, и др.
Опубликовано: (2021-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
по: Fernández-de-Bobadilla Jaime, и др.
Опубликовано: (2007-10-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
по: Sergio Coccheri
Опубликовано: (2017-04-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
по: Caso, V, и др.
Опубликовано: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
по: Caso, V, и др.
Опубликовано: (2012)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
по: Mikkel B. Christensen, и др.
Опубликовано: (2021-06-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
по: Price, H, и др.
Опубликовано: (2009)

Aspirin for prevention of cancer and cardiovascular disease.
по: Rose, P, и др.
Опубликовано: (2011)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
по: Patrono, C, и др.
Опубликовано: (2010)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
по: Nischal N Hegde, и др.
Опубликовано: (2023-01-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
по: Eleni Giannopoulou, и др.
Опубликовано: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
по: Athena L. Huang, и др.
Опубликовано: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
по: Athena L. Huang, MD, и др.
Опубликовано: (2023-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
по: N. В. Perepech, и др.
Опубликовано: (2018-05-01)

Antiplatelets in secondary stroke prevention
по: Olga eShulga, и др.
Опубликовано: (2011-07-01)

Antioxidant vitamins--benefits not yet proved.
по: Hennekens, C, и др.
Опубликовано: (1994)